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Use of clinical syndromes to target antibiotic prescribing in seriously
ill children in malaria endemic area: observational study
James A Berkley, Kathryn Maitland, Isaiah Mwangi, Caroline Ngetsa, Saleem Mwarumba, Brett S Lowe, Charles R J C
Newton, Kevin Marsh, J Anthony G Scott, Mike English
Abstract
Objectives To determine how well antibiotic treatment is
targeted by simple clinical syndromes and to what extent drug
resistance threatens affordable antibiotics.
Design Observational study involving a priori definition of a
hierarchy of syndromic indications for antibiotic therapy
derived from World Health Organization integrated
management of childhood illness and inpatient guidelines and
application of these rules to a prospectively collected dataset.
Setting Kilifi District Hospital, Kenya.
Participants 11 847 acute paediatric admissions.
Main outcome measures Presence of invasive bacterial
infection (bacteraemia or meningitis) or Plasmodium falciparum
parasitaemia; antimicrobial sensitivities of isolated bacteria.
Results 6254 (53%) admissions met criteria for syndromes
requiring antibiotics (sick young infants; meningitis/
encephalopathy; severe malnutrition; very severe, severe, or
mild pneumonia; skin or soft tissue infection): 672 (11%) had
an invasive bacterial infection (80% of all invasive bacterial
infections identified), and 753 (12%) died (93% of all inpatient
deaths). Among P falciparum infected children with a syndromic
indication for parenteral antibiotics, an invasive bacterial
infection was detected in 4.0-8.8%. For the syndrome of
meningitis/encephalopathy, 96/123 (76%) isolates were fully
sensitive in vitro to penicillin or chloramphenicol.
Conclusions Simple clinical syndromes effectively target
children admitted with invasive bacterial infection and those at
risk of death. Malaria parasitaemia does not justify withholding
empirical parenteral antibiotics. Lumbar puncture is critical to
the rational use of antibiotics.
Introduction
Invasive bacterial infections are an important cause of childhood
illness and death worldwide. To develop effective guidelines for
initial antimicrobial treatment, knowledge of the likely cause of
illness and the pattern of antibiotic resistance are fundamental.
However, many resource poor countries lack local data and look
to the World Health Organization for guidance. Advice on the
management of common conditions has recently been summa-
rised in the context of the integrated management of childhood
illness approach.1 Diagnosis in such settings usually depends on
the identification of a small number of clinical syndromes. Seri-
ously ill children often meet criteria for several clinical
syndromes, however, and different diseases may cause the same
clinical syndrome.2 In malaria endemic areas uncertainty may
exist because the clinical manifestations of malaria overlap with
those of pneumonia, bacteraemia, and meningitis.3–12
We aimed to determine how well antibiotic treatment is
targeted by simple rules based on current WHO guidelines, how
application of such rules is affected by malaria parasitaemia in an
endemic area, and to what extent antibiotic resistance threatens
the use of cheap antibiotics. These analyses aim to reflect the
practical decisions faced by clinicians, rather than simply
describing the antimicrobial sensitivities of individual bacterial
species or the bacterial aetiology of diseases defined at discharge.
Methods
Location and clinical methods
Kilifi District Hospital is located in a rural area on the Kenyan
coast; a Kenya Medical Research Institute centre is based at the
hospital. Children receive up to 50 mosquito bites infective for
Plasmodium falciparum annually, with two transmission seasons.13
Ten per cent of women attending the hospital antenatal clinic in
2000 were infected with HIV.14 Haemophilus influenzae type b
conjugate vaccination had not begun at the time of the study.
Government employed clinical officers, without training in the
integrated management of childhood illness, referred children to
the paediatric wards.
We recruited all children admitted from February 1999 to
December 2001, unless a clinically obvious disorder was present
that was unlikely to cause diagnostic uncertainty, such as elective
surgery, trauma, sickle cell crisis, congenital anomalies, tetanus,
or nephrotic syndrome.2 We collected clinical data, a malaria
slide, full blood count, and blood culture on admission.15 16 Table
1 gives clinical definitions. Our lumbar puncture policy included
any of the following at any time during admission: meningism;
impaired consciousness (delayed until neurologically stable);
prostration in children aged under 3 years; and seizures, other
than simple febrile seizures or as a septic screen in young
infants.17 Inpatient treatment followed WHO and local
guidelines, including recommended protocols for severe malnu-
trition.1
Laboratory methods
We used a BACTEC 9050 instrument (Becton Dickinson, USA)
to process blood cultures, and further processed them by stand-
ard methods. We regarded Staphylococcus epidermidis, Streptococcus
viridans, Bacillus, or Micrococcus species as contaminants. We
counted the leucocytes in cerebrospinal fluid (CSF) in a modified
Neubauer chamber and did Gram stain and latex agglutination
for Haemophilus influenzae type b and Streptococcus pneumoniae
(Murex Diagnostics, UK) if > 10 leucocytes/l were present. We
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assayed glucose in CSF and a concurrent blood sample (Analox
Ltd, UK). We defined bacterial meningitis as positive CSF
culture, positive CSF latex agglutination test, organisms on Gram
stain, CSF leucocytes ≥ 50/l, or CSF:blood glucose ratio < 0.1.17
Antibiotic susceptibilities were determined at the end of the
study (E-test, AB Biodisk, Sweden) at the manufacturer’s labora-
tory and interpreted using National Committee for Clinical
Laboratory Standards guidelines.18 We defined in vitro sensitivity
as “fully sensitive” for children with meningitis and “fully
sensitive” or “intermediately sensitive” for children without men-
ingitis. Isolates from children aged 60 days or older with
confirmed meningitis were classified as resistant to gentamicin
because of poor CSF penetration. Isolates were tested against
individual antibiotics, and sensitivity to an antibiotic combination
was defined as sensitivity to either of the antibiotics alone. Blood
counts were automated (Beckman/Coulter Inc, USA). For
malaria diagnosis, we stained a thick and thin blood slide with
Giemsa and examined it at x1000. Laboratory procedures were
internally and externally quality controlled (www.neqas.com).
Analysis
For the purposes of this analysis only, we classified children as
meeting the definition of a syndrome warranting antibiotic treat-
ment (table 1) or not by using data collected on admission. We
constructed an a priori hierarchy of the syndromes, reflecting
prioritisation in clinical practice (figure). We did not use the out-
patient integrated management of childhood illness syndrome
of “very severe febrile disease,”19 as we would expect referral care
to be further rationalised. We assigned individual children to
their highest priority syndrome. We compared proportions by
using Fisher’s exact test and explored the possibility that antibi-
otic resistance increased the risk of inpatient death by using mul-
tiple logistic regression. We labelled individuals as “resistant to
treatment” if the organism isolated was resistant in vitro to the
antibiotics defined by their syndrome. Terms included in the
multiple regression model included age ( < 7 or ≥ 7 days), sex,
meningitis, malnutrition, and malaria. We used Stata version 8.0
for statistical analysis.
Results
Among 14 987 admissions, we excluded 1254 (8.4%) with an
obvious diagnosis, 134 ( < 1%) with missing data or refusal to
consent, and 1752 (12%) with contaminated blood cultures, leav-
ing 11 847 admissions (table 2).We detected an invasive bacterial
infection in 843 (7.1%) admissions (table 3): 633 (5.3%) positive
blood culture only, 9 ( < 0.1%) positive CSF culture only, 111
(0.9%) positive blood and CSF cultures, 21 (0.2%) positive blood
culture with CSF evidence of meningitis, and 69 (0.6%) CSF evi-
dence of meningitis but negative cultures. We detected P
falciparum parasitaemia in 5270 (45%) admissions. A defined
syndrome requiring antibiotics was present in 6254 (53%)
admissions; of these, 672 (11%) had an invasive bacterial
infection, representing 80% of all invasive bacterial infections,
and 753 (12%) died in hospital, representing 93% of 813
inpatient deaths.
Sick young infants
Of 1267 young infants, 184 (15%) had an invasive bacterial
infection (table 3), principally group B streptococci, E coli,
Acinetobacter, and Klebsiella spp (table 4). The proportion of
isolates susceptible in vitro to ampicillin-gentamicin was greater
than that resistant to either penicillin-gentamicin or cefotaxime
(both P = 0.001) (table 5).
Meningitis/encephalopathy syndrome
This clinical syndrome captured 101/160 (63%) cases of labora-
tory defined meningitis in children at least 60 days old; 21 (13%)
other cases of meningitis outside this syndrome definition met
another syndrome definition indicating parenteral antibiotics.
The remaining 38 (24%) cases of meningitis would not have ini-
tially received parenteral antibiotics if syndromic treatment rules
(that do not rely on lumbar puncture) had been followed
Table 1 Definition of clinical syndromes and currently recommended
antibiotic treatment
Syndrome Definition
Recommended antibiotic
treatment*
Sick young infants Any child <60 days old sick
enough to warrant admission
to hospital
Gentamicin with either
penicillin or ampicillin
Meningitis/encephalopathy Neck stiffness, bulging
fontanel, or impaired
consciousness†
Penicillin with
chloramphenicol
Severe malnutrition Severe wasting‡ or
kwashiorkor
Gentamicin with either
penicillin or ampicillin
Very severe pneumonia Respiratory distress§ plus
one or more of prostration¶,
cyanosis, or hypoxia**
Chloramphenicol
Severe pneumonia Respiratory distress§ Penicillin
Mild pneumonia Tachypnoea†† plus a history
of either cough or difficulty
breathing
Oral amoxicillin
Skin or soft tissue infection Cellulitis, abscess,
pyomyositis
Cloxacillin
*Parenteral unless otherwise indicated.
†Blantyre coma score ≤2.5
‡Weight for age z score <−4 by NCHS standards (Epi Info 2000, CDC, Atlanta, USA).
§Lower chest wall indrawing or abnormally deep breathing.
¶Inability to sit unassisted if aged ≥1 year or inability to drink or breastfeed if aged <1 year.6
**SaO2<90% in air by pulse oximetry (Nellcor, USA).
††≥50 breaths per minute if aged 60 days to 1 year; ≥40 breaths per minute if ≥1 year old.1
Admissions (n=11 847)
No defined syndrome (n=5593)
Sick young infants (n=1267)
Meningitis/encephalopathy (n=820)
Severe malnutrition (n=1182)
Pneumonia (n=2803)
Skin/soft tissue infection (n=182)
Very severe pneumonia (n=296)
Severe pneumonia (n=1470)
Mild pneumonia (n=1037)
Hierarchical classification of defined syndromes requiring antibiotic treatment
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absolutely. The most common isolates were S pneumoniae and H
influenzae (table 4). Four hundred and twenty two (52%) children
with this syndrome had a positive malaria slide; 29 (6.9%) of
these had an invasive bacterial infection compared with 117/397
(30%) children with negative slides (P < 0.001, table 3). Case
fatality did not vary significantly with malaria parasitaemia. Only
76% of isolates were fully sensitive in vitro to penicillin-
chloramphenicol compared with 93% for cefotaxime (P < 0.001,
table 5). When we excluded H influenzae, 86% of isolates were
sensitive to penicillin-chloramphenicol. Susceptibility results
were similar when all meningitis cases missed by this syndrome
definition were included.
Severe malnutrition syndrome
Severe malnutrition syndrome accounted for 141/659 (21%) of
invasive bacterial infections and 200/533 (38%) of deaths in chil-
dren aged at least 60 days (table 3). S pneumoniae, E coli, and non-
typhoidal salmonellae were the most common isolates (table 4).
Most (959, 81%) of these admissions did not meet criteria for
another syndrome requiring antibiotics, making anthropometry
or kwashiorkor the sole basis for antibiotic treatment. Of these,
Table 2 Clinical characteristics of study participants. Values are numbers
(percentages) unless stated otherwise
Characteristic Participants* (n=11 847)
Median (interquartile range) age (months) 17 (7 to 35)
Girls 5494 (46)
History of fever 9822/11 838 (83)
History of cough 5275/11 838 (45)
History of difficulty breathing 4065/11 838 (34)
History of diarrhoea 2545/11 838 (22)
History of convulsions 2719/11 837 (23)
Mean (SD) weight for age z score −1.84 (1.50)
Kwashiorkor 766/11 833 (6.5)
Axillary temperature ≥37.5°C 7273/11 813 (62)
Impaired consciousness 734/11 835 (6.2)
Tachypnoea 4064/11 741 (35)
Subcostal indrawing 2317 /11 834 (20)
Deep breathing 737/11 836 (6.2)
Anaemia (Hb<8 g/dl) 4584/11 813 (39)
Severe anaemia (Hb<5 g/dl) 1173/11 813 (9.9)
Malaria parasitaemia 5 270/11 786 (45)
*Denominators less than 11 847 indicate missing data.
Table 3 Number of admissions with defined syndromes, prevalence of invasive bacterial infections, malaria parasitaemia, and outcome. Values are numbers
(percentages) unless stated otherwise
Syndrome
Median (IQR) age
(months)
Invasive
bacterial
infection* Meningitis Deaths
Malaria slide
positive
Invasive bacterial infection*
Malaria positive Malaria negative
Sick young infants (n=1267) 7 (2-22) days 184 (15) 50 (4.0) 280 (22) 34 (2.7) 2/34 (5.9) 176/1213 (15)
Meningitis/encephalopathy
(n=820)
27 (13-46) 147 (18) 101 (12) 150 (18) 422 (52) 29/422 (6.9) 117/397 (30)
Severe malnutrition (n=1182) 24 (15-39) 141 (12) 3 (0.3) 200 (17) 376 (32) 33/376 (8.8) 108/802 (13)
Very severe pneumonia
(n=296)
13 (5-29) 33 (11) 8 (2.7) 56 (19) 124 (42) 5/124 (4.0) 28/172 (16)
Severe pneumonia (n=1470) 10 (5-20) 88 (6.0) 5 (0.3) 52 (3.5) 455 (31) 18/455 (4.0) 69/1004 (6.9)
Mild pneumonia (n=1037) 17 (10-29) 69 (6.7) 8 (0.8) 15 (1.5) 526 (51) 16/526 (3.0) 52/509 (10)
Skin/soft tissue infection
(n=182)
19 (10-36) 10 (5.5) 0 0 86 (47) 1/86 (1.2) 9/95 (9.5)
No defined syndrome
(n=5593)
23 (11-44) 171 (3.1) 35 (0.6) 60 (1.1) 3247 (58) 53/3247 (1.6) 118/2324 (5.1)
All admissions (n=11 847) 17 (7-35) 843 (7.1) 210 (1.8) 813 (6.9) 5270 (45) 157/5270 (3.0) 677/6516 (10)
IQR=interquartile range.
*Includes meningitis and bacteraemia.
Table 4 Bacterial isolates cultured. Values are numbers (percentages*)
Bacterial isolates
Sick young
infants
Meningitis/
encephalitis
Severe
malnutrition
Very severe
pneumonia
Severe
pneumonia Mild pneumonia
Skin/soft tissue
infection
No defined
syndrome Total
Gram positive
Streptococcus
pneumoniae
13 (8) 47 (37) 40 (27) 14 (44) 28 (31) 29 (43) 1 (10) 30 (19) 202
Staphylococcus
aureus
16 (9) 5 (4) 5 (3) 1 (3) 2 (2) 3 (4) 4 (40) 18 (12) 54
Group A streptococci 13 (8) 5 (4) 3 (2) 2 (6) 0 1 (1) 1 (10) 5 (3) 30
Group B streptococci 20 (12) 0 0 0 0 0 0 0 20
Other Gram positives† 8 (5) 1 (1) 4 (3) 1 (3) 0 4 (6) 0 4 (3) 22
Gram negative
Non-typhoidal
salmonellae
3 (2) 9 (7) 25 (17) 2 (6) 18 (20) 16 (24) 0 44 (28) 117
Haemophilus
influenzae
8 (5) 36 (29) 12 (8) 5 (16) 18 (20) 6 (9) 0 16 (10) 101
Escherichia coli 19 (11) 3 (2) 31 (21) 2 (6) 11 (12) 3 (4) 0 7 (5) 76
Acinetobacter sp 17 (10) 6 (5) 9 (6) 2 (6) 6 (7) 1 (1) 1 (10) 11 (7) 53
Klebsiella sp 17 (10) 1 (1) 4 (3) 0 (0) 2 (2) 0 1 (10) 2 (1) 27
Pseudomonas sp 9 (5) 6 (5) 2 (1) 1 (3) 2 (2) 1 (1) 1 (10) 4 (3) 26
Other Gram
negatives†
30 (17) 7 (6) 13 (9) 2 (6) 2 (2) 4 (6) 1 (10) 14 (9) 73
Total 173 126 148 32 89 68 10 155 801
*Percentages refer to columns.
†Other common isolates in admissions ≥60 days included group D streptococci (10), Campylobacter sp (4), Enterobacter sp (3), and Shigella sp (3). Other common isolates in young infants
included Aeromonas sp (7), Enterobacter sp (7), and group D streptococci (6).
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88 (9.2%) had an invasive bacterial infection and 153 (16%) died,
compared with 53 (24%) and 47 (21%) of the 223 who met other
syndrome definitions (both P < 0.001). The prevalence of
invasive bacterial infection was higher in children with negative
malaria slides than in those with positive slides (P = 0.02, table 3).
Case fatality was lower in admissions with negative malaria slides
(166/802, 21%) than in those with positive slides (34/376, 9.0%)
(P < 0.001). In vitro susceptibility to amoxicillin-gentamicin was
greater than that to penicillin-gentamicin (P < 0.05, table 5).
Pneumonia syndromes
Of 2803 (24%) children admitted with a pneumonia syndrome,
1470 (52%) had severe disease and 296 (11%) had very severe
disease. The prevalence of invasive bacterial infection with severe
pneumonia syndrome was similar to that with mild pneumonia
syndrome, but case fatality was greater (P = 0.001, table 3). S
pneumoniae (38%), Enterobacteriaceae (30%), and H influenzae
(15%) were the most common isolates (table 4). Three to four per
cent of children with a positive malaria slide had an invasive bac-
terial infection compared with 6.9-16% in those with a negative
slide (all P < 0.001, table 3). Case fatality did not vary significantly
with malaria parasitaemia. Isolates from children with severe or
very severe pneumonia were more commonly susceptible to
chloramphenicol alone than to penicillin alone (P = 0.05) and to
ampicillin-gentamicin than to penicillin-gentamicin (P = 0.04,
table 5).
Skin or soft tissue infection syndrome
Ten (5.5%) of 182 children with skin or soft tissue infections had
an invasive bacterial infection. Staphylococcus aureus accounted
for four (40%) invasive infections, and all these were sensitive to
cloxacillin.
No defined syndrome requiring antibiotics
Of 5593 children without a syndrome requiring antibiotics, 171
(3.1%) had an invasive bacterial infection and 60 (1.1%) died.
Non-typhoidal salmonellae, S pneumoniae, and S aureus were the
most common isolates (table 4). Of 2324 malaria slide negative
admissions, 118 (5.1%) had an invasive bacterial infection
compared with 53/3247 (1.6%) slide positive admissions
(P < 0.001). Among children with an axillary temperature
≥ 39°C, invasive bacterial infection was present in 47/488 (9.6%)
with a negative malaria slide compared with 22/1422 (1.6%) with
a positive slide (P < 0.001). We found no significant association
between invasive bacterial infection and prostration, seizures,
diarrhoea, vomiting, jaundice, or severe anaemia. Among
children with an invasive bacterial infection, 0/53 children with a
positive malaria slide died compared with 11/118 (9.3%) of
those with a negative slide (P = 0.02). In those without an invasive
bacterial infection, 20/3194 (0.6%) children with a positive
malaria slide died compared with 29/2216 (1.3%) with a
negative slide (P = 0.009).
Antimicrobial resistance and outcome
Antibiotic resistance to recommended treatment was associated
with an odds ratio of 1.22 (95% confidence interval 0.78 to 1.92)
for fatal outcome. If only deaths after 24 hours of admission were
examined, the association with a fatal outcome strengthened
(odds ratio = 1.90, 0.95 to 3.80), but the possibility of no associa-
tion could not be absolutely excluded.
Discussion
Clinical officers and doctors at hospitals in sub-Saharan Africa
face considerable challenges in managing seriously ill children,
having few resources for diagnosis or treatment. Good early
management is important because most deaths occur within 48
hours of admission. Initially, the management of seriously ill
children is largely independent of the underlying cause. It
includes resuscitation and correction of life threatening compli-
cations such as hypoxaemia, hypovolaemia, hypoglycaemia, con-
vulsions, and severe anaemia. Antibiotics and antimalarials can
be effective only if such complications are recognised and
adequately treated.
Syndromic rules effectively target children with invasive
bacterial infections
We have found that among acute paediatric admissions to a
Kenyan district hospital, simple clinical syndromes based on
WHO guidelines identified at admission 80% of children with an
invasive bacterial infection and 93% of subsequent inpatient
deaths. For every nine children with a defined syndrome indicat-
ing antibiotic treatment, one child had an identified invasive bac-
terial infection. Given the likely insensitivity of blood culture, we
think this justifies empirical antibiotic treatment.
Does a positive malaria slide justify withholding antibiotics?
Overall, the presence of P falciparum parasitaemia was associated
with a lower risk of invasive bacterial infection. However, where a
syndrome requiring parenteral antibiotics (meningitis/
encephalopathy, malnutrition, very severe or severe pneumonia)
was present, children with a positive malaria slide (by quality
controlled microscopy in a research setting) still had a risk of
detectable invasive bacterial infection between 1 in 25 and 1 in
11 and a risk of dying between 1 in 28 and 1 in 6 (table 3 and
results section). We believe that these risks are too high to justify
withholding parenteral antibiotics because a malaria slide is
positive.
Table 5 In vitro antimicrobial susceptibilities (E-test)*. Values are percentages
Antibiotics
Young infants
(n=167)
Meningitis/
encephalitis
(n=123)
Severe
malnutrition
(n=141)
Very severe
pneumonia
(n=30)
Severe
pneumonia
(n=84)
Mild pneumonia
(n=64)
Skin/soft tissue
infection (n=8)
No defined
syndrome
(n=141)
Amoxicillin/ampicillin 55 70 57 73 56 72 50 59
Co-trimoxazole 73 34 42 43 36 56 88 54
Benzyl penicillin 31 33 32 50 34 47 38 28
Chloramphenicol 76 76 77 83 74 83 100 81
Penicillin and gentamicin 88 51 81 68 73 83 88 77
Ampicillin and gentamicin 97 81 87 84 85 91 88 88
Penicillin and
chloramphenicol
82 76 77 83 74 83 100 82
Cefotaxime 86 93 94 93 92 98 88 93
*E-test was done on 758 (95%) isolates. Percentages refer to the proportion of isolates sensitive to the antibiotic or combination. For admissions with confirmed meningitis, sensitivity is taken
as the NCCLS “sensitive” breakpoint. For children aged ≥60 days with confirmed meningitis, isolates were classified as not susceptible to gentamicin because of poor penetration in cerebrospinal
fluid. In admissions without meningitis, sensitivity is taken as NCCLS “intermediate” or “sensitive.”
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For children with the syndrome of mild pneumonia and a
positive malaria slide, the case for withholding antibiotics
strengthens: within this group, 1 in 33 had an identified invasive
bacterial infection and 1 in 66 died. Given that blood cultures are
less sensitive than other tests such as lung aspiration,20 21 that
treatment with oral amoxicillin is relatively inexpensive, and that
the overall potential antibiotic pressure on resistance exerted by
this group would be small, dual treatment of children in hospital,
as is common in outpatient populations,8 seems justified.
The accuracy of reading malaria slides in the region is an
important concern. Recent reports suggest that this investigation
is commonly unreliable, with frequent false positives.22 23 Among
children with a clinical syndrome compatible with cerebral
malaria, such false positives would have a 1 in 3 chance of inva-
sive bacterial infection. Children with the mild pneumonia
syndrome and a false positive malaria slide would have a 1 in 10
chance. The unreliability of malaria microscopy in practice
further considerably strengthens the case for following
syndromic indications for antibiotic treatment, irrespective of the
malaria slide result.
Among those with an axillary temperature ≥ 39°C but with-
out a defined syndromic indication for antibiotics, an accurate
malaria slide may be helpful in deciding on antibiotic treatment:
1 in 10 of those with a negative malaria slide had an “occult”
invasive bacterial infection, whereas invasive bacterial infection
was rare in children with positive slides and the outcome signifi-
cantly better, although we did not establish how many of these
children actually received antibiotics.
Does a syndrome indicating antibiotic treatment justify
withholding antimalarials?
A third of children with a syndrome requiring antibiotics had a P
falciparum parasitaemia, and 24% of the deaths in this group
were due to malaria in the absence of invasive bacterial infection.
Thus, among children admitted to hospital, suspected or micro-
scopically confirmed malaria should be treated with antimalar-
ials regardless of any antibiotic treatment. Where the results of a
malaria slide are unreliable, children with features of severe
malaria (impaired consciousness, deep breathing, or both)
should receive both parenteral antimalarials and antibiotics. Oral
antimalarials are likely to be adequate for those not classified as
severe.
Meningitis: problems with clinical diagnosis and
antimicrobial resistance
One in four cases of meningitis presented without a clinical syn-
drome indicating parenteral antibiotic treatment. Results were
similar when more detailed clinical indicators of meningitis were
studied in this hospital.24 Meningitis was identified because our
lumbar puncture protocol was broader than the syndrome defi-
nition, including suspicion of meningitis arising after admission.
The pivotal role of lumbar puncture in rationalising treatment
underlines the need to improve the use of this investigation17:
88% of children with the syndrome did not have meningitis.
Lumbar puncture therefore permits considerable cost savings,
especially where there is significant resistance to inexpensive
antibiotics.25 The high sensitivity to amoxicillin-gentamicin asso-
ciated with this syndrome reflects the proportion of children
with bacteraemia but not meningitis. Interestingly, H influenzae
type b immunisation may reduce the need for more expensive
antibiotics such as third generation cephalosporins.
Conclusions
We have shown that simple rules based on a hierarchical classifi-
cation of WHO integrated management of childhood illness
clinical syndromes can target admissions with invasive bacterial
infections and those at risk of death. Our findings in this study,
and previous studies,2 15 indicate that the antibiotic management
of children admitted to hospital in settings with no or few diag-
nostic resources should reflect a comprehensive assessment of
the sick child and not focus on single diseases. A checklist
illustrating such an approach is shown in the box. Our data are
limited by being from one district hospital and using in vitro sus-
ceptibility testing (E-test). Similar studies are needed from other
ecological zones in sub-Saharan Africa, especially areas with dif-
ferent prevalences of malaria and HIV. The potential impact on
the aetiology of invasive bacterial infections of improved preven-
tive strategies such as immunisation and changing patterns of
resistance underscore the need for sustained surveillance in
countries such as Kenya.
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Checklist for a syndromic, non-single disease approach
to the management of children admitted to hospital
All of these questions should be answered for all children ill
enough to warrant admission to hospital
• Does this child need immediate cardiopulmonary resuscitation
(airway, breathing, circulation), including oxygen, fluid
resuscitation, urgent blood transfusion*, glucose, or
anticonvulsants?26–28
• Does this child meet criteria for a clinical syndrome(s)
requiring antibiotic treatment? The types of antibiotic and route
of administration will depend on the clinical syndrome—treat the
most severe classification
• Does this child have a clinical syndrome indicating antimalarial
treatment? The need for antimalarials will depend on a history of
fever (presumptive treatment) or having reliable microscopy. The
type of drug and route of administration will depend on whether
or not signs of severe malaria (impaired consciousness, deep
“acidotic” breathing, or both) are present1 29
• Is this child severely malnourished? WHO recommends that
protocols for drugs, fluids, and nutritional support should be
followed for children with severe malnutrition, even if treatments
for malaria or bacterial syndromes are being given1
• Does this child have another obvious diagnosis?
• Does this child need a lumbar puncture to diagnose or exclude
meningitis?24
• What maintenance oxygen, fluids, glucose, anticonvulsants,
haematinics, or other drugs are needed?
• What level of observation or monitoring does this child need?
• When should this child be reviewed?
*Fluid resuscitation and blood transfusion protocols vary with
the presence or absence of severe malnutrition
Papers
BMJ Online First bmj.com page 5 of 6
Competing interests: None declared.
Ethical approval: The Kenya Medical Research Institute national ethical
and scientific review committees approved the study.
1 World Health Organization. Management of the child with a serious infection or severe mal-
nutrition: guidelines at the first referral level in developing countries. Geneva: WHO, 2000.
2 English M, Berkley J, Mwangi I, Mohammed S, Ahmed M, Osier F, et al. Hypothetical
performance of syndrome-based management of acute paediatric admissions of
children aged more than 60 days in a Kenyan district hospital. Bull WHO 2003;81:166-
73.
3 Molyneux ME, Taylor TE,Wirima JJ, Borgstein A. Clinical features and prognostic indi-
cators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J
Med 1989;71:441-59.
4 Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, et al. Indicators of
life-threatening malaria in African children.N Engl J Med 1995;332:1399-404.
5 O’Dempsey TJ, McArdle TF, Laurence BE, Lamont AC, Todd JE, Greenwood BM.
Overlap in the clinical features of pneumonia and malaria in African children. Trans R
Soc Trop Med Hyg 1993;87:662-5.
6 English M, Punt J, Mwangi I, McHugh K, Marsh K. Clinical overlap between malaria
and severe pneumonia in Africa children in hospital. Trans R Soc Trop Med Hyg
1996;90:658-62.
7 Perkins BA, Zucker JR, Otieno J, Jafari HS, Paxton L, Redd SC, et al Evaluation of an
algorithm for integrated management of childhood illness in an area of Kenya with
high malaria transmission. Bull World Health Organ 1997;75(suppl 1):33-42.
8 Kallander K, Nsungwa-Sabiiti J, Peterson S. Symptom overlap for malaria and
pneumonia—policy implications for home management strategies. Acta Trop
2004;90:211-4.
9 Berkley J, Mwarumba S, Bramham K, Lowe B, Marsh K. Bacteraemia complicating
severe malaria in children. Trans R Soc Trop Med Hyg 1999;93:283-6.
10 Evans JA, Adusei A, Timmann C, May J, Mack D, Agbenyega T, et al. High mortality of
infant bacteraemia clinically indistinguishable from severe malaria. Q J Med
2004;97:591-7.
11 Berkley JA, Mwangi I, Mellington F, Mwarumba S, Marsh K. Cerebral malaria versus
bacterial meningitis in children with impaired consciousness.Q J Med 1999;92:151-7.
12 Prada J, Alabi SA, Bienzle U. Bacterial strains isolated from blood cultures of Nigerian
children with cerebral malaria. Lancet 1993;342:1114.
13 Mbogo CM,Mwangangi JM, Nzovu J, Gu W, Yan G, Gunter JT, et al. Spatial and tempo-
ral heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission
along the Kenyan coast. Am J Trop Med Hyg 2003;68:734-42.
14 Ministry of Health, Republic of Kenya. AIDS in Kenya. 6th ed. Nairobi: Government of
Kenya, 2001.
15 Berkley JA, Ross A,Mwangi I, Osier F, Ahmed M, Shebbe M, et al. Prognostic indicators
of early and late death in children admitted to a Kenyan district hospital. BMJ
2003;326:361-7
16 Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, et al. Bacteremia
among children admitted to a rural hospital in Kenya.N Engl J Med 2005;352:39-47.
17 Berkley JA, Mwangi I, Mwarumba S, Lowe B, Marsh K, Newton CRJC. Diagnosis of
acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. Lan-
cet 2001;357:1753-7.
18 National Committee of Clinical and Laboratory Standards. M100-S7: performance
standards for antimicrobial testing. Pennsylvania, USA: NCCLS,1997.
19 Tulloch J. Integrated approach to child health in developing countries. Lancet
1999;354(suppl 2):16-20.
20 Falade AG, Mulholland EK, Adegbola RA, Greenwood BM. Bacterial isolates from
blood and lung aspirate cultures in Gambian children with lobar pneumonia. Ann Trop
Paediatr 1997;17:315-9.
21 Falade AG, Adegbola RA, Mulholland EK, Greenwood BM. Respiratory rate as a pre-
dictor of positive lung aspirates in young Gambian children with lobar pneumonia.Ann
Trop Paediatr 2001;21:293-7.
22 Makani J, Matuja W, Liyombo E, Snow RW, Marsh K, Warrell DA. Admission diagnosis
of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical
description.Q J Med 2003;96:355-62.
23 Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al.
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospec-
tive study. BMJ 2004;329:1212.
24 Berkley JA, Versteeg AC, Mwangi I, Lowe BS, Newton CR. Indicators of acute bacterial
meningitis in children at a rural Kenyan district hospital. Pediatrics 2004;114:e713-9.
25 Duke T, Micheal A, Mokela D, Wal T, Reeder J. Chloramphenicol or ceftriaxone, or
both, as treatment for meningitis in developing countries.Arch Dis Child 2003;88:536-9.
26 Advanced paediatric life support: the practical approach. 1st ed. London: BMJ Publishing
Group, 1993.
27 Tamburlini G, Di Mario S, Maggi RS, Vilarim JN, Gove S. Evaluation of guidelines for
emergency triage assessment and treatment in developing countries. Arch Dis Child
1999;81:478-82.
28 RobertsonMA,Molyneux EM. Triage in the developing world—can it be done? Arch Dis
Child 2001;85:218-3.
29 World Health Organization. Severe falciparum malaria. Trans Royal Soc Trop Med Hyg
2000;94(suppl 1).
(Accepted 22 February 2005)
doi 10.1136/bmj.38408.471991.8F
Centre for Geographic Medicine Research (coast), PO Box 230, Kilifi, Kenya
James A Berkley clinical research fellow
Kathryn Maitland clinical research fellow
Isaiah Mwangi clinical researcher
Caroline Ngetsa laboratory technologist
Saleem Mwarumba laboratory technologist
Brett S Lowe laboratory manager
Charles RJC Newton senior clinical research fellow
Kevin Marsh professor
J Anthony G Scott clinical research fellow
Mike English clinical research fellow
Correspondence to: J A Berkley jberkley@kilifi.mimcom.net
What is already known on this topic
Local data on bacterial aetiology and antimicrobial
susceptibilities of childhood diseases are sparse in
sub-Saharan Africa
Treatment guidelines for children in this setting tend to
focus on individual diseases, which may lead to uncertainty
where several causes of illness are possible
The clinical manifestations of severe malaria overlap with
those of invasive bacterial infection, and malaria microscopy
may be unreliable, causing further uncertainty
What this study adds
A simple hierarchical classification of clinical syndromes
seems to effectively target admissions with invasive bacterial
infection and those at risk of death
A positive malaria slide does not seem to justify
withholding parenteral antibiotic treatment where it is
indicated by a syndrome requiring antibiotics
A practical approach is to make separate decisions
regarding antibiotic, antimalarial, and other treatments on
the basis of the presence of defined clinical syndromes and
the results of any reliable laboratory investigations
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